Related Experiment Videos

Staphylococcal post-sternotomy mediastinitis: five year audit

Arlo Upton1, Sally A Roberts, Paget Milsom

  • 1Department of Clinical Microbiology, Auckland District Health Board, New Zealand. aupton@fhcrc.org

ANZ Journal of Surgery
|April 21, 2005
PubMed
Abstract

Insights

Staphylococcal mediastinitis affects 1.2% of patients after sternotomy, with diabetes and ethnicity as key risk factors. This serious infection has high mortality and relapse rates, necessitating optimized prevention and management strategies.

Area of Science:

  • Medical research
  • Infectious disease epidemiology
  • Surgical outcomes

Background:

  • Post-sternotomy mediastinitis (PSM) occurs in 0.8-2.3% of cases, frequently caused by staphylococci.
  • Obesity and diabetes are established risk factors for PSM.
  • Staphylococcal PSM presents significant morbidity and mortality.

Purpose of the Study:

  • To determine the incidence of staphylococcal PSM.
  • To identify risk factors for staphylococcal PSM.
  • To audit the management of staphylococcal PSM.

Main Methods:

  • Retrospective review of clinical records for staphylococcal PSM cases (1998-2003).
  • Data collection included demographics, comorbidities, operation type, microbiology, management, and outcomes.
  • Comparison with a prospective cardiac surgery database.

Main Results:

  • Incidence of staphylococcal PSM was 1.2% (60/5176 sternotomies).
  • Staphylococcus aureus (82%) and coagulase-negative staphylococci (18%) were identified; 16% of S. aureus were methicillin-resistant.
  • Risk factors included ethnicity, diabetes, emergency surgery, ejection fraction, and preoperative stay length. In-hospital mortality was 15%; 18% had treatment failure.

Conclusions:

  • Staphylococcal mediastinitis is a severe complication with substantial mortality and relapse rates.
  • The study highlights the need for optimized prevention and management of surgical site infections.
  • Clinical pathways require evaluation to improve outcomes for staphylococcal PSM.

Related Concept Videos

Mitral Stenosis III: Medical Management01:26

Mitral Stenosis III: Medical Management

Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
Endocarditis III: Medical Management01:18

Endocarditis III: Medical Management

Infective endocarditis management involves a multifaceted approach encompassing infection prevention, lifestyle modifications, pharmacological therapy, and surgical management.Infection Prevention:Hand Hygiene: Thorough handwashing is crucial to prevent the spread of infection. Hand hygiene should be performed regularly, especially before and after using the restroom.Oral Hygiene: Good oral hygiene is essential. It includes brushing teeth immediately after waking up and before bed, flossing...
Staphylococcal Skin Infections01:29

Staphylococcal Skin Infections

Staphylococcus aureus is a Gram-positive coccus that resides harmlessly on the skin and mucous membranes of healthy individuals. When the skin barrier is breached, it can shift from a commensal to an opportunistic pathogen. This transition is facilitated by surface adhesins, such as clumping factor B and S. aureus surface protein G (SasG), which bind to structural proteins, including loricrin and cytokeratin, in the damaged epidermis. Protein A, another key factor, binds the Fc region of...